$AAQL
Antiaging Quantum Living Inc.

2023 Q3 Form 10-K Financial Statement

#000149315223024592 Filed on July 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q1 2023
Revenue $13.60K
YoY Change 83.78%
Cost Of Revenue
YoY Change
Gross Profit $13.60K
YoY Change 115.87%
Gross Profit Margin 100.0%
Selling, General & Admin $24.38K $50.23K
YoY Change 224.2% -2.1%
% of Gross Profit 369.34%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization -$80.00 $314.00
YoY Change -200.0% 214.0%
% of Gross Profit 2.31%
Operating Expenses $24.38K $50.23K
YoY Change 224.18% -2.1%
Operating Profit -$24.38K -$36.63K
YoY Change 1503.82% -18.62%
Interest Expense $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$24.38K -$36.63K
YoY Change 1503.82% -15.67%
Income Tax
% Of Pretax Income
Net Earnings -$24.38K -$36.63K
YoY Change 1503.82% -15.68%
Net Earnings / Revenue -269.34%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 30.00M shares 30.00M shares 30.00M shares
Diluted Shares Outstanding 30.00M shares 30.00M shares

Balance Sheet

Concept 2023 Q3 2023 Q1 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $55.03K $350.00
YoY Change 4133.08% -97.55%
Cash & Equivalents $55.03K $354.00 $350.00
Short-Term Investments
Other Short-Term Assets $27.55K
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables $27.55K
Total Short-Term Assets $82.59K $354.00 $350.00
YoY Change 6248.04% -97.52% -97.55%
LONG-TERM ASSETS
Property, Plant & Equipment $383.00 $540.00 $540.00
YoY Change -45.05% -36.77% -36.47%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $383.00 $540.00 $540.00
YoY Change -45.05% -36.77% -36.47%
TOTAL ASSETS
Total Short-Term Assets $82.59K $354.00 $350.00
Total Long-Term Assets $383.00 $540.00 $540.00
Total Assets $82.97K $894.00 $890.00
YoY Change 4052.7% -94.09% -94.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.92K $901.00 $900.00
YoY Change
Accrued Expenses $901.00
YoY Change
Deferred Revenue $2.800K
YoY Change -50.0%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $115.3K $83.30K
YoY Change 62.68% 41.19%
Total Short-Term Liabilities $139.9K $87.00K $87.00K
YoY Change 88.78% 34.68% 34.67%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $139.9K $87.00K $87.00K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $139.9K $87.00K $87.00K
YoY Change 88.78% 34.68% 34.67%
SHAREHOLDERS EQUITY
Retained Earnings -$330.4K -$276.3K
YoY Change 25.96% 15.28%
Common Stock $30.00K $30.00K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$56.91K -$86.11K -$86.11K
YoY Change
Total Liabilities & Shareholders Equity $82.97K $894.00 $890.00
YoY Change 4052.7% -94.09% -94.11%

Cashflow Statement

Concept 2023 Q3 2023 Q1 2023
OPERATING ACTIVITIES
Net Income -$24.38K -$36.63K
YoY Change 1503.82% -15.68%
Depreciation, Depletion And Amortization -$80.00 $314.00
YoY Change -200.0% 214.0%
Cash From Operating Activities -$29.99K -$38.22K
YoY Change 209.81% -7.11%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 98.04K $24.30K
YoY Change 890.3% -302.5%
NET CHANGE
Cash From Operating Activities -29.99K -$38.22K
Cash From Investing Activities
Cash From Financing Activities 98.04K $24.30K
Net Change In Cash 68.05K -$13.92K
YoY Change 30831.82% 330.8%
FREE CASH FLOW
Cash From Operating Activities -$29.99K -$38.22K
Capital Expenditures
Free Cash Flow -$38.22K
YoY Change -4.91%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001672571
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
usd
CY2023Q1 us-gaap Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
http://achison.com/20230331#ShareholdersMember
CY2022Q1 us-gaap Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
http://achison.com/20230331#ShareholdersMember
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2023 us-gaap Interest Income Other
InterestIncomeOther
usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
CY2023 us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2023 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023 us-gaap Development Costs
DevelopmentCosts
usd
CY2023Q1 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2800 usd
CY2022Q1 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
usd
CY2023 ACHN Income Tax Reconciliation Change In Operating Loss Carryforwards
IncomeTaxReconciliationChangeInOperatingLossCarryforwards
usd
CY2022 ACHN Income Tax Reconciliation Change In Operating Loss Carryforwards
IncomeTaxReconciliationChangeInOperatingLossCarryforwards
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
000-56157
CY2023 dei Entity Registrant Name
EntityRegistrantName
Antiaging Quantum Living Inc.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-2643986
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
1345 Avenue of the Americas
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
33rd Floor
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10105
CY2023 dei City Area Code
CityAreaCode
917
CY2023 dei Local Phone Number
LocalPhoneNumber
470-5393
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2022Q3 dei Entity Public Float
EntityPublicFloat
146268 usd
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
29995000 shares
CY2023 dei Auditor Firm
AuditorFirmId
2485
CY2023 dei Auditor Name
AuditorName
Simon & Edward, LLP
CY2023 dei Auditor Location
AuditorLocation
Rowland Heights, CA
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
354 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14269 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
354 usd
CY2022Q1 us-gaap Assets Current
AssetsCurrent
14269 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
540 usd
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
854 usd
CY2023Q1 us-gaap Assets
Assets
894 usd
CY2022Q1 us-gaap Assets
Assets
15123 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
901 usd
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5600 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
83300 usd
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
59000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
87001 usd
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
64600 usd
CY2023Q1 us-gaap Liabilities
Liabilities
87001 usd
CY2022Q1 us-gaap Liabilities
Liabilities
64600 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29995000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29995000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29995000 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29995000 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
29995 usd
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
29995 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
160230 usd
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
160230 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-276332 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-239702 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-86107 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-49477 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
894 usd
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15123 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13600 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7400 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
1100 usd
CY2023 us-gaap Gross Profit
GrossProfit
13600 usd
CY2022 us-gaap Gross Profit
GrossProfit
6300 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
50230 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
51310 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
50230 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
51310 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-36630 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-45010 usd
CY2022 us-gaap Interest Income Other
InterestIncomeOther
1574 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1574 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-36630 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-43436 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-36630 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-43436 usd
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29995000 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29995000 shares
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.001
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.001
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-6041 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-43436 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-49477 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-36630 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-86107 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-36630 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-43436 usd
CY2023 us-gaap Depreciation
Depreciation
314 usd
CY2022 us-gaap Depreciation
Depreciation
96 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
901 usd
CY2023 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-2800 usd
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
2200 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-38215 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-41140 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
950 usd
CY2022 us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
50863 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
49913 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
24300 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
5000 usd
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
17000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
24300 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-12000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-13915 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3227 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14269 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
17496 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
354 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14269 usd
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
CY2023 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2014-12-29
CY2023 us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
NOLs can carry forward indefinitely up to offset 80 percent of taxable income after CARES Act effect on December 31, 2017.
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_840_eus-gaap--UseOfEstimates_zanzeYPMUic5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_863_ztx2SU1Hcb1h">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and the rules and regulations of the Securities and Exchange Commission (the “SEC”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the Company’s financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and footnotes thereto. Actual results may differ from those estimates and assumptions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P10Y
CY2019Q3 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
10000000 shares
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.075 pure
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-36630 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-276332 usd
CY2023Q1 ACHN Working Capital
WorkingCapital
-86647 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2800 usd
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5600 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-276332 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-239702 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.075 pure
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
29122 usd
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
11945 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
29122 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
11945 usd

Files In Submission

Name View Source Status
0001493152-23-024592-index-headers.html Edgar Link pending
0001493152-23-024592-index.html Edgar Link pending
0001493152-23-024592.txt Edgar Link pending
0001493152-23-024592-xbrl.zip Edgar Link pending
achn-20230331.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
form10-k_002.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
achn-20230331_cal.xml Edgar Link unprocessable
achn-20230331_def.xml Edgar Link unprocessable
achn-20230331_lab.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
achn-20230331_pre.xml Edgar Link unprocessable